QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A review of S100 protein family in lung cancer 期刊论文 CLINICA CHIMICA ACTA, 2018, 卷号: 476, 页码: 54-59 作者:  Wang, Ting;  Huo, Xiaoying;  Chong, Zhaoyang;  Khan, Hamadhaider;  Liu, Rui 收藏  |  浏览/下载：6/0  |  提交时间：2019/11/26 S100 calcium binding proteins  Lung cancer  Biomarker   Evaluation of the acute and chronic toxicity of the jiangu capsules 期刊论文 EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 卷号: 14, 页码: 6229-6237 作者:  Lan, Zengmei;  Wang, Liping;  Chong, Zhaoyang;  Yang, Guangde;  Yu, Xiaojiang 收藏  |  浏览/下载：4/0  |  提交时间：2019/11/26 biochemical parameters  organ weights  histopathological examination  hematological parameters  jiangu capsule   Amantadine inhibits cellular proliferation and induces the apoptosis of hepatocellular cancer cells in vitro 期刊论文 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 卷号: 36, 期号: [db:dc_citation_issue], 页码: 904-910 作者:  Lan, Zengmei;  Chong, Zhaoyang;  Liu, Cong;  Feng, Danyang;  Fang, Dihai 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/02 cell cycle  hepatocellular carcinoma  cell viability  amantadine  apoptosis   FIRST-LINE ERLOTINIB VERSUS CISPLATIN/GEMCITABINE (GP) IN PATIENTS WITH ADVANCED EGFR MUTATION-POSITIVE NON-SMALL-CELL LUNG CANCER (NSCLC): INTERIM ANALYSES FROM THE PHASE 3, OPEN-LABEL, ENSURE STUDY 会议论文 作者:  Wu, Yi-Long;  Liam, Chong-Kin;  Zhou, Caicun;  Wu, Gang;  Liu, Xiaoqing 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/19 EGFR mutations  Asian patients  erlotinib  NSCLC   A developmental perspective on high power laser facility technology for ICF 期刊论文 SOLID STATE LASERS XXVII: TECHNOLOGY AND DEVICES, 卷号: 10511 作者:  Zhu, Jianqiang;  Sun, Mingying;  Liu, Chong;  Guo, Yajing;  Yang, Lin 收藏  |  浏览/下载：23/0  |  提交时间：2018/12/25 Status and development of high-power laser facilities at the NLHPLP 期刊论文 HIGH POWER LASER SCIENCE AND ENGINEERING, 卷号: 6 作者:  Zhu, Jianqiang;  Zhu, Jian;  Li, Xuechun;  Zhu, Baoqiang;  Ma, Weixin 收藏  |  浏览/下载：37/0  |  提交时间：2018/12/25